News

brinksreport22m
AstraZeneca’s Masterstroke! $5.3B AI Deal with China’s CSPC Shakes Big Pharma
AstraZeneca is making a bold move. The drug giant just teamed up with CSPC in a deal worth up to $5.3 billion. The goal? To ...
Pharmaceutical Technology47m
EHA 2025: AstraZeneca’s surovatamig is potential next-gen BiTE for R/R B-ALL
Surovatamig shows promise, but needs to outperform established therapies such as Blincyto and Aucatzyl.
PMLive59m
AstraZeneca and CSPC Pharmaceuticals enter AI-driven partnership worth $5.3bn
AstraZeneca (AZ) and CSPC Pharmaceuticals Group have entered into a partnership worth up to $5.3bn to develop therapies for ...